Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantationRichard F. Schlenk, Konstanze Döhner, Helmut R. Salih et al.|Blood|2014Cited by 400
Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failureMohammed Wattad, Daniela Weber, Konstanze Döhner et al.|Leukemia|2017Cited by 118
Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III StudyRichard F. Schlenk, Hartmut Döhner, Peter Paschka et al.|Journal of Clinical Oncology|2019Cited by 111
ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drugBjoern Chapuy, Gerald Wulf|Haematologica|2009Cited by 90
Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-upFrancesco d’Amore, Mats Jerkeman, Massimo Federico et al.|Annals of Oncology|2025Cited by 12